University of California, Los Angeles About Us   |   Diversity and Inclusion  |   Contact Us   |   Campus Directory   |   Giving   |   Maps/Directions

Jeffrey Cummings, M.D.

Contact Information:

Work Phone Number:

(310)794-3665

Work Address:

Mary S. Eason Center for Alzheimer's Disease Research at UCLA
10911 Weyburn Ave., Suite 200
Los Angeles, CA 90095
UNITED STATES

Work Email Address:

jcummings@mednet.ucla.edu

Website:

Home Page.

Professor, Neurology


Awards and Honors:

Boston Medical Center
Hartford Hospital
Dept. of Veterans Affairs Medical Center, Boston
National Hospital

Publications:

Ringman JM, Younkin SG, Pratico D, Seltzer W, Cole GM, Geschwind DH, Rodriguez-Agudelo Y, Schaffer B, Fein J, Sokolow S, Rosario ER, Gylys KH, Varpetian A, Medina LD, Cummings JL   Biochemical markers in persons with preclinical familial Alzheimer disease, Neurology. 2008;71:85-92, 2008; .
Apostolova LG, Cummings JL   Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. Dement Geriatr Cogn Disord., 2008;25:115-126, 2008; .
Salzman Carl, Jeste Dilip V, Meyer Roger E, Cohen-Mansfield Jiska, Cummings Jeffrey, Grossberg George T, Jarvik Lissy, Kraemer Helena C, Lebowitz Barry D, Maslow Katie, Pollock Bruce G, Raskind Murray, Schultz Susan K, Wang Philip, Zito Julie M, Zubenko George S   Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. The Journal of clinical psychiatry, 2008; 69(6): 889-98.
Salloway Stephen, Mintzer Jacobo, Weiner Myron F, Cummings Jeffrey L   Disease-modifying therapies in Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2008; 4(2): 65-79.
Cummings Jeffrey L, Mackell Joan, Kaufer Daniel   Behavioral effects of current Alzheimer's disease treatments: a descriptive review. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2008; 4(1): 49-60.
Cummings Jeffrey L   Optimizing phase II of drug development for disease-modifying compounds. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2008; 4(1 Suppl 1): S15-20.
UCLA    |    Terms & Conditions    |    Disability Resources    |    UC Regents